세계의 유전자 융합 검사 시장

This report provides detailed information on the global gene fusion testing market. It highlights current and future market trends, as well as a comprehensive competitive landscape. The report analyzes market trends with data from 2024, estimates from 2025, and projections of compound annual growth rates (CAGRs) through 2030.

Report Scope

The report provides an overview of the gene fusion testing market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025 and projected data for 2026 through 2030.

The market is segmented by technology, indication and end user. By technology, the market is segmented into fluorescence in situ hybridization (FISH), next-generation sequencing (NGS), polymerase chain reaction (PCR) and immunohistochemistry (IHC). By indication, it is segmented into hematological cancer and solid tumor. By end user, the market comprises pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, as well as academic and research centers. Geographical regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America.

The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It also discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the leading gene fusion testing companies. It also contains a dedicated section of company profiles that covers details such as overview, key financials, product portfolio and recent developments in major companies.

Report Includes

• Overview and an analysis of the global market for gene fusion testing technologies
• Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
• Understanding of the technology background for fusion genes, their applications in cancer research and long-read transcriptome sequencing data
• Estimates of the current market size and revenue prospects, along with a corresponding market share analysis based on the technology type, disease indication, end user and region
• Facts and figures pertaining to the global market dynamics, opportunities and deterrents, technological advancements, regulations, prospects and the impact of macroeconomic factors
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Profiles of the leading companies in the market

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Technological Advances
• Conclusion

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate)
• Bargaining Power of Suppliers (Moderate to High)
• Bargaining Power of Buyers (High)
• Threat of Substitutes (Low)
• Competition in the Industry (High)
• Macroeconomic Factors Analysis
• Healthcare Spending
• Aging Population
• U.S. Tariff Scenario

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Incidence of Cancer
• Rising Adoption of Personalized Medicine
• Market Restraints
• High Cost of Advanced Testing Method
• Complex Reimbursement Coverage of Gene Fusion Testing
• Market Opportunities
• Emerging Markets
• Increasing Awareness and Early Cancer Detection Programs
• Market Challenges
• Shortage of Skilled Professionals

Chapter 4 Emerging Technologies and Developments

• Emerging Technologies
• Single-Molecule Long-Read Sequencing
• CRISPR-Based Fusion Detection
• Digital PCR (dPCR) and Multiplex qPCR Assays
• Artificial Intelligence (AI)

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Technology
• Key Takeaways
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescence in Situ Hybridization (FISH)
• Immunohistochemistry (IHC)
• Market Analysis by Indication
• Key Takeaways
• Solid Tumor
• Hematological Cancer
• Market Analysis by End User
• Key Takeaways
• Pharmaceutical and Biotechnology Companies
• Hospitals and Diagnostic Laboratories
• Academic and Research Centers
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• South America

Chapter 6 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Leading Companies of Gene Fusion Testing Market
• Key Developments and Strategies

Chapter 7 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AMOY DIAGNOSTICS CO. LTD.
• BIOCARE MEDICAL LLC.
• BIOCARTIS
• F. HOFFMANN-LA ROCHE LTD.
• GUARDANT HEALTH INC.
• ILLUMINA INC.
• INTEGRATED DNA TECHNOLOGIES INC.
• MYRIAD GENETICS INC.
• QIAGEN
• THERMO FISHER SCIENTIFIC INC.
• Few Emerging Startups/Market Disruptors